Abstract: From anesthetized rats in the 90s to conscious wild-type or knockout mice today, intracerebral in vivo microdialysis provided important information about the brain mechanism of action of psychotropic drugs such as antidepressants. The principle of microdialysis technique is based on the balance between the release of neurotransmitters (e.g., serotonin 5-HT, norepinephrine, dopamine) and re-uptake by selective transporters (e.g., SERT for 5-HT). Complementary to electrophysiology, this technique reflects brain tissue content. It has been proposed that the inhibitory role of 5-HT1A and 5-HT1B serotonergic receptor subtypes that limit somatodendritic and nerve terminal 5-HT release, respectively, play a key role in the mechanism of action of Selective Serotonin Reuptake Inhibitors (SSRI). This hypothesis is based partially on results of microdialysis experiments performed in Rodents. Examples from our this statement.
INTRODUCTION
Most of the antidepressants such as Selective Serotonin Reuptake Inhibitors (SSRI) act as indirect agonists of monoamine receptors. While SSRI drugs produce relatively rapid blockade of serotonin (5-hydroxytryptamine, 5-HT) transporters (SERT) in vitro takes several (4-6) weeks to occur [1] . This gap in timing between SSRI near-immediate effect on neurotransmitter systems and the slow symptomatic recovery is a paradox that has not been completely solved yet. At presynaptic level, SSRI-induced blockade of SERT results in a rapid suppression of electrophysiological technique in anesthetized animals.
Another technique has provided complementary information about the mechanism of action of SSRIs intracerebral in vivo microdialysis and relevant publications from other investigators.
presynaptic release of 5-HT and intrasynaptic events. With its coupling to very sensitive analytical techniques, it has provided much information regarding changes in the local presynaptic release of monoamines following acute drug administration. Thus, it has been possible to obtain two major arguments supporting the hypothesis that somatodendritic 5-HT1A autoreceptors located in the raphe nuclei play an important role in the mechanism of action of SSRIs in rats learned that a single administration of SSRIs at low doses comparable to those used therapeutically, increased 5-HText in the vicinity of the cell body and the dendrites of serotoninergic neurones of the dorsal raphe nucleus (DRN) [4] . This effect was more pronounced than that observed in regions rich [6] . Hence, the magnitude of the activation of the serotonergic neurotransmission depends on the brain area studied and the dose of the SSRIs administered to rats. This difference has been attributed to the activation activation of somatodendritic 5-HT1A autoreceptors by endogenous 5-HT in the raphe nuclei, thereby limiting the corticofrontal effects of the antidepressant. Microdialysis technique demonstrated that, despite SSRI-induced 5-HT reuptake inhibition also taking place at nerve terminals, there is a decrease in 5-HT release via activation of 5-HT1A (somatodendritic) or 5-HT1B (nerve terminal) autoreceptors [7] . Thus, depending on the terminal 5-HT brain area, only a small increase or in rats, have then been extended to measure SSRI-induced changes in DRN 5-HText in awake, freely moving knockout mice [9, 10].
Next, we have learned from microdialysis performed in rats that SSRIs cause a larger increase in 5-HText at nerve endings following an acute treatment versus a chronic one. As the treatment is prolonged, a robust and time-dependent downregulation of the 5-HT transporter SERT was observed depend on 5-HT1A autoreceptor internalization [16] . Indeed, we studied the function of the 5-HT system in the raphe nuclei and hippocampus by using repeated in vivo microdialysis sessions in awake freely moving mice. We assessed the degree of 5-HT1A autoreceptor desensitization by using a local infusion of the 5-HT1A receptor antagonist, WAY 100635 in the raphe via reverse amplitude with 5-HT1A autoreceptor desensitization, but neither with the basal extracellular levels anxiolytic/antidepressant-like effects of chronic SSRI treatment depend on 5-HT1A autoreceptor internalization, but do not require a sustained increase in extracellular 5-HT levels in a territory of these experimental results, suggesting that co-administration of a 5-HT1A autoreceptor antagonist (pindolol) and a SSRI accelerated the onset of the antidepressant effect [17] . However, given the complex pharmacology of pindolol, new drug developments may help to discover either selective and silent 5-HT1A receptor antagonists to be prescribed in combination with SSRIs, or dual action stem cells, but more recently, temporal and spatial controls of gene expression were possible in adult been mostly performed in healthy, "not depressed" animals. In the mid-90s, genetically manipulated mice became available. It complicated the experimental protocol because it was necessary to include littermates as wild-type (WT) control mice. Great hopes were placed in mutant lines, some of them being considered as putative animal models of anxiety or depression. Several lines of transgenic (Tg) mice (carrying a human gene) or knockout (KO) mice (i.e., homozygous mice lacking the two copies of a gene coding for a receptor or transporter of neurotransmitter or neuropeptide) were have a human equivalent, (ii) many biological and biochemical functions of the mouse are similar to those of humans, and (iii) the genome mouse is easily manipulated by homologous recombination. This technique allowed the creation of animal-related patterns of human brain pathologies. The genetic background
At that time, the procedure of intracerebral in vivo microdialysis needed to be quickly adapted to perform experiments in an animal model having a smaller brain size than rats. Microdialysis probe must be macroscopically verify according to the stereotaxic coordinates given by the mouse models of anxiety -depression was remarkably appropriate because it is now well recognized that major depressive disorders result from a combination of genetic and environmental factors. In addition, to develop animal models that present behavioral, neurochemical and brain morphological phenotypes They display decreased exploratory activity and increased fear of aversive environments and exhibited a decreased immobility in the forced swim test, an effect commonly associated with antidepressant the most interesting applications of microdialysis is to allow the study of basal extracellular levels brain region where 5-HText is known to regulate serotonergic transmission through activation of 5-HT1A autoreceptors. When microdialysis was performed in the DRN, it was found that baseline Furthermore, microdialysis helped to decipher the brain region-dependent effects of antidepressants. The same group of researchers used a recently developed genetic mouse system to independently manipulate 5-HT1A autoreceptor and heteroreceptor populations. They found that 5-HT1A autoreceptors affect anxiety-like behavior, while 5-HT1A heteroreceptors affect responses to forced swim stress, without effects on anxiety-like behavior [36] . These results establish distinct roles for the two receptors' populations, providing evidence that signaling through endogenous 5-HT1A of psychiatric disorders and their treatments.
being interesting animal models of anxiety and depression. These mice are very helpful to discover the underlying pathological mechanisms that limit the effects of current treatments of major depressive episodes and to identify the nature of the molecular cascades leading to the installation of disorders treatment with antidepressants.
Changes in the amount of neurotransmitters (mainly monoamines such as serotonin, 5-hydroxytryptamine, 5-HT, norepinephrine, NE, and dopamine, DA) in synapses can be viewed as near-immediate effects of SSRI on brain neurotransmitter systems. In vivo brain microdialysis allows to measure basal extracellular levels of these neurotransmitters giving an idea of neurochemical events occurring at nerve terminals in brain regions of awake, freely moving rodents. In our laboratory, we extensively applied this technique in genetic and pharmacological studies aimed at investigating the relationship between neurotransmitters and brain regions, or between neurochemical changes and animal behaviors (see examples below). Among the main interests of microdialysis application is the as in WT mice used as controls in these pharmacological experiments [e.g., intra-raphé perfusion of Recent advances in experimental approaches using genetically manipulated mice have already been
[41]). Therefore, the remainder of the present chapter will only describe some examples, which explain these statements.
onset of action, partly due to the activation of somatodendritic 5-HT1A autoreceptors by the excess extracellular 5-HT produced by SSRI in the raphe nuclei. A group of scientists in Spain recently interfering RNA (siRNA) to suppress acutely 5-HT1A autoreceptor-mediated negative feedback mechanisms in the mouse brain. They developed a conjugated siRNA (C-1A-siRNA) by covalently binding siRNA targeting 5-HT1A receptor mRNA with the SSRI sertraline in order to concentrate it in serotonin axons, rich in serotonin transporter (SERT) sites. The intracerebroventricular (i.c.v.) infusion of C-1A-siRNA to mice resulted in its selective accumulation in serotonin neurons. This was associated with anti-depressant-like effects in the forced swim and tail suspension tests, but did not affect anxiety-like behaviors in the elevated plus-maze. In addition, C-1A-siRNA administration hypothermia (a pre-synaptic 5-HT1A receptor effect in mice) without affecting postsynaptic 5-HT1A receptor expression in the hippocampus and prefrontal cortex. Moreover, i.c.v. C-1A-siRNA infusion as monotherapy or in combination with SSRI.
To learn whether or not the in vitro in vivo microdialysis data, we studied whether a single administration of a range of doses (1, 4 and 5-HText and norepinephrine (NEext) by using in vivo microdialysis in the frontal cortex of awake, freely moving mice [43] . We found that citalopram and paroxetine have the highest potency to is similar, and greater than that of venlafaxine. Thus, the highest doses of the very selective SSRI citalopram, and the very potent SSRI paroxetine were able to increase cortical NEext. Surprisingly, the SNRI venlafaxine increased cortical 5-HText to a greater extent rather than NEext in the range of doses studied in mice. The potency and selectivity of SSRIs as determined in vitro do not take into account noradrenergic projections and others which obviously interfer in vivo, but not in vitro. Thus, function of monoamines transporters are much more complex than previously thought. In vivo experiments help to depict this complexity when it is possible to measure correlation between neurochemical parameters and behavior.
MICRODIALYSIS: PRINCIPLE AND METHODOLOGY IN MICE
The principle of microdialysis technique is based on the balance between the release of neurotransmitters
IN VIVO
neurons, glial cells and blood vessels [45] . It contains various monoamines, excitatory and inhibitory amino acids, neuropeptides and their metabolites as well as precursors of these neurotransmitters. In in vivo anesthetized rodents, then in awake, freely moving animals.
In vivo microdialysis technique, in anesthetized or awake animals, was developed by the group of porous membrane from the compartment with the highest concentration of neurotransmitters (the synaptic extracellular space) to the less concentrated compartment (i.e., the dialysis probe perfused with a buffer solution at physiological pH that does not contain neurotransmitters) (Figure 1 ). This technique, now currently applied in our laboratory in awake, freely moving WT control or knockout These samples contain, among other molecules, serotonin (5-HT), its major metabolite (5-HIAA) and using high-performance liquid chromatography coupled to an amperometric detector (e.g., 1049A, dependent neurotransmitter release and its reuptake by the selective carrier (e.g., SERT or 5-HTT . Indeed, this neurotrophic factor is known to play a role in mood disorders and the mechanism of action of antidepressant drugs. However, the relationship between BDNF and BDNF on the 5-HT system and the activity of the serotonin transporter (SERT) in the hippocampus. The hippocampus and decreased 5-HT reuptake capacity. These results are coherent with the lack of effect of paroxetine to increase hippocampal 5-HText levels in BDNF +/-mice, while it produced robust effects in wild-type littermates. As expected, in-vitro autoradiography and synaptosome techniques synaptosomes. Taken together, these results provide evidence that constitutive reductions in BDNF modulate SERT function reuptake in the hippocampus. [44]) indicates the duration time of the forced swim test (i.e., 6 minutes), which was performed, in a separate group of animal, at the maximum effect of the antidepressant on cortical extracellular 5-HT levels in mice. It emphasizes that microdialysis and behavioral experiments were carried out by using the same experimental protocol.
SEROTONIN, KO MICE AND MICRODIALYSIS
Depressive disorders result from a combination of genetic and environmental factors. By using microdialysis, we can also study changes in dialysate 5-HT levels in the dorsal raphe nucleus contribution. This experiment can give further information when combined with measurements of the WT mice is very informative.
Neurochemical changes as measured by using microdialysis can have functional consequences since they correlated with behavioural data obtained, for example, in the forced swim test (FST). Three on swimming behavior was potentiated by BDNF. These data suggest an interesting synergy between BDNF and SSRI on 5-HT neurotransmission, thus such a co-administration improved the immobility time in both strains of mice, but the response was much greater in 5HT 1A these results suggest that the genetic inactivation of 5-HT1A receptors, abolished the inhibitory feedback control exerted by somatodendritic 5-HT1A autoreceptors, thus enhancing the response of mutant mice to stressful conditions such as the FST. Thus, following SSRI administration, an indirect activation of presynaptic 5-HT1A receptors by endogenous 5-HT may limit its antidepressant-like effects in the FST in wild type mice. (e.g., into the raphe nuclei for the neuronal 5-HT system), and a probe into a serotonergic nerve terminal region (hippocampus, frontal cortex), thus evaluating a neural circuit. of the drug. Even more interesting when the drug do not cross easily the blood brain barrier -Measurements of several neurotransmitters in the same sample [44] . -Study the same animal for two consecutive days, each one being used as its own control, e.g., treatment.
-When using a guide cannula, it's possible to collect samples in the same animal once a week for several weeks [16] . -When applied in awake, freely moving animals, functional consequences of SSRI-induced increases in extracellular neurotransmitter levels can be studied, e.g., correlation between thermoregulatory process involving the functional activity of somatodendritic 5-HT1A receptors These data indicate that 5-HT can be taken into DA neurons in rodents when SERT is not functionally adequate to remove extracellular 5-HT levels, and (c) the DA transporter is responsible for the 5-HT uptake into DA neurons. Thus, dysfunctional. Thus, when using mice lacking an important protein from the earliest period of their existence, one has to be aware that compensatory alterations may occur in the brain as well as at the periphery. This point must be considered when it comes to interpretation of the experimental results.
(in the hippocampus and frontal cortex), every 10 minutes in raphe nuclei. This is due to the compared to the technique of reference, electrophysiology (400 milliseconds).
-3 to 6 months to complete an experiment, i.e., to evaluate the effects of several doses of an agonist -antagonist compared to mice treated with the vehicle or wild-type (WT) mice (a control groups). Even longer when using transgenic mice (breeding, genotyping, selection of -Effect of stress, delicate animal handling, so it requires an experienced experimenter mm). mice, it is necessary to verify the exact location of the probe implantation, macroscopically on brain coronal sections [70] .
basal extracellular concentrations of 5-HT, DA and NA.
5-HIAA levels decrease, independently of the dose of the indirect 5-HT receptor agonist administered. These changes are not related to the neuronal activity [4, 73] .
CONCLUSION:
Neuropharmacology. They help to identify in animals susceptibility genes and proteins involved in the pathological processes leading to anxiety and depression. These biological markers could then be helpful to pose the diagnosis of the disease in human. They also give information on their functional dysfunctions having behavioral consequences similar to those associated with endogenous depression 5-HT1B, 5-HT1A and 5-HT4 receptors) display changes in phenotypes similar to those induced by chronic treatment with antidepressants in WT control mice.
Chronic antidepressant treatment may regulate the expression of neurotrophic factors such as BDNF and stimulate the process of adult neurogenesis in the dentate gyrus of the hippocampus in rats [74] and adult mice [75, 76] . Changes in adult neurogenesis are only seen after chronic, but not acute, contributed to this knowledge by exploring the relationship between the hippocampal 5-HT system (i.e., the function of its transporter, one of the main targets of antidepressants), and brain BDNF levels.
In the future, our efforts to understand the pathophysiology of mood disorders, especially anxiety/ depression, will focus on the antidepressant responses, especially in non-stressed and stressed rodents.
relationships between brain neurotransmitters and circuits involved in the mechanism of action of an antidepressant drugs' polytherapy, soon available on the market. Furthermore, original strategies temporally controlled manner in mice. For example, it well known that agonists of the 5-HT1A
increased anxiety-like behavior (as indicated above). However, the relevant brain regions involved in 5-HT1A receptor gene was under the control of the antibiotic doxycycline. The gene of interest was switched off when the mice were fed with the antibiotic. They used autoradiography to demonstrate that high levels of postsynaptic 5-HT1A receptor expression in the hippocampus and cortex of the rescue mice, but the presynaptic 5-HT1A autoreceptor, was undetectable in the raphe nuclei. By using mice in which the 5-HT1A receptor can be knocked out at will, they show that the absence of the receptor in newborns lead to anxiety-like behavior, whereas its knockout during adult life has no effect. In addition, they found that postnatal developmental processes help to establish adult anxietylike behavior. Generating such a rescue mice is a long lasting process, but each animal can be used as its own control. generated was used as the control group. To our knowledge, this strategy has not already been applied [53] Benmansour for the measurement of serotonin in microdialysates using capillary high-performance liquid capillary electrophoresis separation of amino acid neurotransmitters from brain microdialysis of variations in extracellular levels of serotonin, GABA and excitatory amino acids in the frontal protein and extraneuronal 5-HT in mice with reduced serotonin transporter or BDNF expression. J
